Kyung Hee Han

Dr. Kyung Hee Han


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
PDF file
KHKyung Hee Han
Kyung Hee Han
NPNOHHYUN PARK
NOHHYUN PARK
MLMaria Lee
Maria Lee
CLCheol Lee
Cheol Lee
HKHyojin Kim
Hyojin Kim
Han KH, et al. J Gynecol Oncol. 2024 Jan;35:e59. https://doi.org/10.3802/jgo.2024.35.e59

5 November 2017 in Gynecological Endocrinology
Verified
Journal Article
Closed access
SKSunmie Kim
Sunmie Kim
JKJin Ju Kim
Jin Ju Kim
MKMin-Jeong Kim
Min-Jeong Kim
KHKyung Hee Han
Kyung Hee Han
JLJung Ryeol Lee
Jung Ryeol Lee
SKSeok Hyun Kim
Seok Hyun Kim
The relationship between serum anti-Mullerian hormone (AMH) with vitamin D (25OH-D) and metabolic syndrome (MetS) risk was evaluated in healthy, late reproductive-age (35–49 years) women with regular menstrual cycles. Among the 291 participants (mean age = 42.5 years), most (76.6%, n = 223) were serum vitamin D insufficient (<20 ng/ml). Mean serum levels of AMH and vitamin D were 2.04 ng/mL and 15.9 ng/mL, respectively. There was no correlation between AMH and 25OH-D after adjustment for age (r = −0.093, p = 0.113). Subjects with higher MetS score, higher waist circumference, and higher diastolic blood pressure had significantly higher serum AMH levels when adjusted for age, but the association attenuated when BMI was included. There was no significant correlation between MetS risk components with serum level of AMH or vitamin D. In conclusion, there was no association between AMH with serum 25OH-D or MetS risk factors in this population.

1 January 2019 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
KHKyung Hee Han
Kyung Hee Han
NPNOHHYUN PARK
NOHHYUN PARK
JKJin Ju Kim
Jin Ju Kim
SKSunmie Kim
Sunmie Kim
HKHee Seung Kim
Hee Seung Kim
Yong Sang SongYong Sang Song
Yong Sang Song
To identify the power of tumor markers for predicting ovarian cancer according to menopausal status. The medical records of 876 women with ovarian cysts were retrospectively reviewed. Cancer antigen 125 (CA 125), human epididymis protein 4 (HE4), and Risk of Ovarian Malignancy Algorithm (ROMA) were analyzed. Sensitivity, specificity, and the receiver operating characteristic (ROC) curve analyses of these tumor markers were evaluated. The sensitivity of ROMA was 66.7% and the specificity was 86.8% to detect ovarian malignancy. The patients were divided into 2 groups according to menopausal status: premenopause (n=532, 60.7%) and postmenopause (n=344, 39.3%). For diagnostic accuracy, ROMA was lower than HE4 in premenopausal women (82.7% vs. 91.4%) and lower than CA 125 in postmenopausal women (86.9% vs. 88.7%). The ROC curve analysis revealed that the power of ROMA was not significantly better than that of HE4 in premenopausal women (area under the curve [AUC], 0.731 vs. 0.732, p=0.832), and it was also not significantly better than that of CA 125 in postmenopausal women (AUC, 0.871 vs. 0.888, p=0.440). The discrimination power of tumor markers for ovarian cancer was different according to menopausal status. In predicting ovarian malignancy, ROMA was neither superior to HE4 in premenopausal women nor superior to CA 125 in postmenopausal women.

22 July 2025 in JMIR Research Protocols
Verified
Journal Article
Open access
JLJee Young Lee
Jee Young Lee
JRJu-Won Roh
Ju-Won Roh
KHKyung Hee Han
Kyung Hee Han
MKMin-Jeong Kim
Min-Jeong Kim
YNYoung Jeong Na
Young Jeong Na
JLJoohyun LEE
Joohyun LEE
Background: Reducing blood pressure fluctuations during surgery is a key objective in improving patient outcomes. Although acupuncture has been suggested as a potential noninvasive intervention for blood pressure modulation, its effectiveness in reducing intraoperative fluctuations remains unclear. Objective: This study aims to investigate whether acupuncture can help stabilize blood pressure during surgery, particularly in women undergoing laparoscopic hysterectomy, a procedure known to cause marked hemodynamic changes during the early intraoperative phase. Methods: This is a prospective, single-center, randomized controlled clinical trial with a parallel-group design. Forty-eight adult patients scheduled to undergo a total laparoscopic hysterectomy are eligible for this study. Participants who provide consent will be randomly assigned in a 1:1 ratio to the acupuncture or placebo groups. They will be followed up for at least 14 days to assess the safety of the intervention, general anesthesia, and surgery. Researchers will compare the difference between the highest and lowest mean blood pressures from anesthesia induction to the postincision period as the primary endpoint. As secondary outcomes, systolic, diastolic, and mean blood pressures will be compared at each predetermined timepoint. The incidences of hypotension, hypertension, tachycardia, and bradycardia will be determined separately. The use of remifentanil at the early stage of surgery, rate of surgical discontinuation, and length of hospital stay will be assessed as surrogate indicators of stable general anesthesia and surgical procedures. For patient-reported outcomes, the Spielberger State-Trait Anxiety Inventory and EQ-5D-5L will be used to evaluate changes in anxiety and overall quality of life. This study may support the use of acupuncture as a complementary intervention to help maintain hemodynamic stability during laparoscopic hysterectomy. The study will be conducted in accordance with the Declaration of Helsinki and has been approved by the Institutional Review Board of CHA Ilsan Medical Center (ICHA 2022-11-010; date of approval: January 03, 2023). Results: Recruitment began in October 2023 and is expected to continue until December 2025. The intervention and data collection procedures are proceeding without major difficulties, with a dropout rate of 11.4%. As of June 2025, a total of 35 participants have been successfully recruited and randomized. Final data analysis is scheduled for completion by March 2026, and the study results are expected to be published in December 2026. Conclusions: This trial will provide valuable evidence on the efficacy of acupuncture for stabilizing intraoperative blood pressure and supporting hemodynamic control during laparoscopic hysterectomy. Trial Registration: ClinicalTrials.gov NCT05720884; https://clinicaltrials.gov/study/NCT05720884 International Registered Report Identifier (IRRID): DERR1-10.2196/77009

18 August 2025 in JMIR Preprints
Verified
Preprint
Open access
JLJee Young Lee
Jee Young Lee
JRJu-Won Roh
Ju-Won Roh
KHKyung Hee Han
Kyung Hee Han
MKMin-Jeong Kim
Min-Jeong Kim
YNYoung Jeong Na
Young Jeong Na
JLJoohyun LEE
Joohyun LEE
UNSTRUCTURED In “Rationale for the Use of Acupuncture to Stabilize Blood Pressure Fluctuations During Total Laparoscopic Hysterectomy: Protocol for a Pilot Parallel-Group Randomized Clinical Trial” ([JMIR Res Protoc 2025;14:e77009]) the authors noted one error/made one addition/made one clarification. Under “Acknowledgments” on page 9, the phrase “… (grant number: RS-2023-KH139140 [HF23C0097])” has been replaced by “… (grant number: RS-2023-KH139468 [HF23C0097]).” Acknowledgments This research is supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health & Welfare, Republic of Korea (grant number: RS-2023-KH139468 [HF23C0097]). The funders had no role in the study design, data collection, analysis, interpretation, manuscript writing, or decision to publish the results.

1 January 2026 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
PDF file
KHKyung Hee Han
Kyung Hee Han
EYEun Jung Yang
Eun Jung Yang
NKNamkyeong Kim
Namkyeong Kim
JSJoo-Hyuk Son
Joo-Hyuk Son
TKTae Wook Kong
Tae Wook Kong
HKHee Seung Kim
Hee Seung Kim
Han KH, et al. J Gynecol Oncol. 2026 ;37:e89. https://doi.org/10.3802/jgo.2026.37.e89